ARTICLE | Company News
QR Pharma, Rockefeller University deal
March 2, 2015 8:00 AM UTC
QR Pharma partnered with the university for preclinical testing of QR’s Posiphen for Huntington’s disease. Rockefeller will use stem cell culture models to determine if Posiphen lowers the levels of ...